Bausch Health Cos Market Cap 2010-2023 | BHC

Bausch Health Cos market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Bausch Health Cos market cap as of April 18, 2024 is $3.16B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.164B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.776B 5.34
Dr Reddy's Laboratories (RDY) India $11.900B 18.82
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $1.957B 13.40
Supernus Pharmaceuticals (SUPN) United States $1.587B 0.00
Taysha Gene Therapies (TSHA) United States $0.458B 0.00
Generation Bio (GBIO) United States $0.198B 0.00
Assembly Biosciences (ASMB) United States $0.071B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.030B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00